Lillian Smith's most recent trade in Allogene Therapeutics Inc was a trade of 56,545 Common Stock done . Disclosure was reported to the exchange on April 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Allogene Therapeutics Inc | Lillian Smith | VP, Corporate Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 56,545 | 140,390 (0%) | 0% | 0 | Common Stock |